PT2830658T - Formulações de agente de ligação igg4 estável - Google Patents
Formulações de agente de ligação igg4 estávelInfo
- Publication number
- PT2830658T PT2830658T PT13714505T PT13714505T PT2830658T PT 2830658 T PT2830658 T PT 2830658T PT 13714505 T PT13714505 T PT 13714505T PT 13714505 T PT13714505 T PT 13714505T PT 2830658 T PT2830658 T PT 2830658T
- Authority
- PT
- Portugal
- Prior art keywords
- binding agent
- agent formulations
- igg4 binding
- stable igg4
- stable
- Prior art date
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261615539P | 2012-03-26 | 2012-03-26 | |
| FR1351013 | 2013-02-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2830658T true PT2830658T (pt) | 2018-12-28 |
Family
ID=54834982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT13714505T PT2830658T (pt) | 2012-03-26 | 2013-03-26 | Formulações de agente de ligação igg4 estável |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP6820823B2 (pt) |
| ES (1) | ES2702246T3 (pt) |
| HK (1) | HK1204990A1 (pt) |
| PT (1) | PT2830658T (pt) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040033228A1 (en) * | 2002-08-16 | 2004-02-19 | Hans-Juergen Krause | Formulation of human antibodies for treating TNF-alpha associated disorders |
| NZ571757A (en) * | 2006-04-21 | 2012-01-12 | Novartis Ag | Antagonist anti-CD40 antibody pharmaceutical compositions comprising arginine-HCl and a citrate or citric acid buffer |
| TW201343676A (zh) * | 2006-08-28 | 2013-11-01 | Kyowa Hakko Kirin Co Ltd | 具拮抗性之人類ｌｉｇｈｔ專一性人類單株抗體 |
| EP2068923A4 (en) * | 2007-03-30 | 2010-11-24 | Medimmune Llc | ANTIBODIES HAVING REDUCED DEAMIDATION PROFILES |
| FI20075278A0 (fi) * | 2007-04-20 | 2007-04-20 | Biotie Therapies Corp | Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet |
| BRPI0815983A2 (pt) * | 2007-08-29 | 2018-05-22 | Sanofi Aventis | anticorpos anti-cxcr5 humanizados, derivados dos mesmos e seus usos |
| FR2942799B1 (fr) * | 2009-03-06 | 2011-02-25 | Lfb Biotechnologies | Anticorps monoclonal anti-rhesus d |
| JO3417B1 (ar) * | 2010-01-08 | 2019-10-20 | Regeneron Pharma | الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r |
| MX2012013586A (es) * | 2010-05-28 | 2013-01-24 | Novo Nordisk As | Composiciones multi-dosis estables que comprenden un anticuerpo y un conservante. |
-
2013
- 2013-03-26 PT PT13714505T patent/PT2830658T/pt unknown
- 2013-03-26 ES ES13714505T patent/ES2702246T3/es active Active
-
2015
- 2015-06-22 HK HK15105917.2A patent/HK1204990A1/xx unknown
-
2017
- 2017-10-25 JP JP2017205914A patent/JP6820823B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6820823B2 (ja) | 2021-01-27 |
| HK1204990A1 (en) | 2015-12-11 |
| JP2018048174A (ja) | 2018-03-29 |
| ES2702246T3 (es) | 2019-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286348A (en) | Pharmaceutical preparations that include allopregnanolone | |
| HK1211188A1 (en) | Nicotine composition | |
| SG11201404577XA (en) | Bactericidal agent composition | |
| IL235322A0 (en) | Pesticides | |
| ZA201500212B (en) | Progesterone formulations | |
| PL2830658T3 (pl) | Stabilne formulacje środków wiążących lgG4 | |
| IL235585B (en) | Substances that bind to ha, preparations containing them and their uses | |
| PL2582761T3 (pl) | Wodne kompozycje środków wiążących | |
| EP2891694A4 (en) | ADHESIVE COMPOSITION | |
| SG11201406278PA (en) | Pesticidal composition | |
| HK1216250A1 (zh) | '- '-羥基-二氫麥角胺化合物及組合物 | |
| IL233824A (en) | Compounds 1h - Indazole - 3 - Carboxamide, preparations containing them and their use | |
| AP3681A (en) | Modified release formulations for oprozomib | |
| ZA201407677B (en) | Nicotine formulation | |
| HK1206976A1 (en) | Composition for agent for external use | |
| HK1209973A1 (en) | Anthracycline formulations | |
| PL2908835T3 (pl) | Stabilne formulacje | |
| ZA201503755B (en) | Herbicide composition | |
| GB201210530D0 (en) | Extended release formulations | |
| GB201105162D0 (en) | Improved deodorant formulations | |
| EP2856873A4 (en) | HERBICIDE COMPOSITION | |
| HK1204990A1 (en) | Stable igg4 binding agent formulations igg4 | |
| GB201206178D0 (en) | Formulations | |
| IL234771A0 (en) | Nicotine formulation | |
| GB201214449D0 (en) | Fragrancing composition |